 | • レポートコード：B-GIR08C1585 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ダクラタスビルの世界市場について調べ、まとめました。種類別セグメントは、30mgテーブル、60mgテーブル等、用途別セグメントは、C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4等に区分しました。ダクラタスビルの世界市場概観、企業動向、企業別ダクラタスビルシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ダクラタスビルの市場概観 ・ダクラタスビルの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ダクラタスビルの企業別販売動向、市場シェア、市場集中度、競争動向 ・ダクラタスビルの世界市場規模 ・ダクラタスビルの北米市場分析（アメリカ、カナダ、メキシコ等） ・ダクラタスビルのアメリカ市場規模推移 ・ダクラタスビルのカナダ市場規模推移 ・ダクラタスビルのメキシコ市場規模推移 ・ダクラタスビルのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ダクラタスビルのドイツ市場規模推移 ・ダクラタスビルのイギリス市場規模推移 ・ダクラタスビルのロシア市場規模推移 ・ダクラタスビルのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ダクラタスビルの日本市場規模推移 ・ダクラタスビルの中国市場規模推移 ・ダクラタスビルの韓国市場規模推移 ・ダクラタスビルのインド市場規模推移 ・ダクラタスビルの東南アジア市場規模推移 ・ダクラタスビルの南米市場分析（ブラジル、アルゼンチン等） ・ダクラタスビルの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ダクラタスビルの種類別分析/販売量、売上、市場シェア（30mgテーブル、60mgテーブル） ・ダクラタスビルの用途別分析/市場規模（C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4） ・ダクラタスビルの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ダクラタスビルの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Daclatasvir is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Daclatasvir in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bristol-Myers Squibb
Natco Pharma
Zydus Cadila
Hetero Drugs
Dr Reddy’s Laboratories
Cipla
Mylan
Abbott
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Biocon
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
30mg Tables
60mg Tables
Market Segment by Applications, can be divided into
Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Daclatasvir product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Daclatasvir, with price, sales, revenue and global market share of Daclatasvir in 2017 and 2018.
Chapter 3, the Daclatasvir competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Daclatasvir breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Daclatasvir market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Daclatasvir sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Daclatasvir Introduction
1.2 Market Analysis by Type
1.2.1 30mg Tables
1.2.2 60mg Tables
1.3 Market Analysis by Applications
1.3.1 Hepatitis C Virus (HCV) Genotype 1
1.3.2 Hepatitis C Virus (HCV) Genotype 3
1.3.3 Hepatitis C Virus (HCV) Genotype 4
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Daclatasvir Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Natco Pharma
2.2.1 Business Overview
2.2.2 Daclatasvir Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Natco Pharma Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Zydus Cadila
2.3.1 Business Overview
2.3.2 Daclatasvir Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Zydus Cadila Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Hetero Drugs
2.4.1 Business Overview
2.4.2 Daclatasvir Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Hetero Drugs Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Dr Reddy’s Laboratories
2.5.1 Business Overview
2.5.2 Daclatasvir Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dr Reddy’s Laboratories Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cipla
2.6.1 Business Overview
2.6.2 Daclatasvir Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Mylan
2.7.1 Business Overview
2.7.2 Daclatasvir Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Mylan Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Abbott
2.8.1 Business Overview
2.8.2 Daclatasvir Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Abbott Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Emcure Pharmaceuticals
2.9.1 Business Overview
2.9.2 Daclatasvir Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Emcure Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Torrent Pharmaceuticals
2.10.1 Business Overview
2.10.2 Daclatasvir Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Torrent Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Biocon
2.11.1 Business Overview
2.11.2 Daclatasvir Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biocon Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Daclatasvir Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Daclatasvir Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Daclatasvir Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Daclatasvir Manufacturer Market Share in 2018
3.3.2 Top 6 Daclatasvir Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Daclatasvir Market Analysis by Regions
4.1 Global Daclatasvir Sales, Revenue and Market Share by Regions
4.1.1 Global Daclatasvir Sales and Market Share by Regions (2014-2019)
4.1.2 Global Daclatasvir Revenue and Market Share by Regions (2014-2019)
4.2 North America Daclatasvir Sales and Growth Rate (2014-2019)
4.3 Europe Daclatasvir Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Daclatasvir Sales and Growth Rate (2014-2019)
4.5 South America Daclatasvir Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Daclatasvir Sales and Growth Rate (2014-2019)
5 North America Daclatasvir by Country
5.1 North America Daclatasvir Sales, Revenue and Market Share by Country
5.1.1 North America Daclatasvir Sales and Market Share by Country (2014-2019)
5.1.2 North America Daclatasvir Revenue and Market Share by Country (2014-2019)
5.2 United States Daclatasvir Sales and Growth Rate (2014-2019)
5.3 Canada Daclatasvir Sales and Growth Rate (2014-2019)
5.4 Mexico Daclatasvir Sales and Growth Rate (2014-2019)
6 Europe Daclatasvir by Country
6.1 Europe Daclatasvir Sales, Revenue and Market Share by Country
6.1.1 Europe Daclatasvir Sales and Market Share by Country (2014-2019)
6.1.2 Europe Daclatasvir Revenue and Market Share by Country (2014-2019)
6.2 Germany Daclatasvir Sales and Growth Rate (2014-2019)
6.3 UK Daclatasvir Sales and Growth Rate (2014-2019)
6.4 France Daclatasvir Sales and Growth Rate (2014-2019)
6.5 Russia Daclatasvir Sales and Growth Rate (2014-2019)
6.6 Italy Daclatasvir Sales and Growth Rate (2014-2019)
7 Asia-Pacific Daclatasvir by Country
7.1 Asia-Pacific Daclatasvir Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Daclatasvir Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Daclatasvir Revenue and Market Share by Country (2014-2019)
7.2 China Daclatasvir Sales and Growth Rate (2014-2019)
7.3 Japan Daclatasvir Sales and Growth Rate (2014-2019)
7.4 Korea Daclatasvir Sales and Growth Rate (2014-2019)
7.5 India Daclatasvir Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Daclatasvir Sales and Growth Rate (2014-2019)
8 South America Daclatasvir by Country
8.1 South America Daclatasvir Sales, Revenue and Market Share by Country
8.1.1 South America Daclatasvir Sales and Market Share by Country (2014-2019)
8.1.2 South America Daclatasvir Revenue and Market Share by Country (2014-2019)
8.2 Brazil Daclatasvir Sales and Growth Rate (2014-2019)
8.3 Argentina Daclatasvir Sales and Growth Rate (2014-2019)
8.4 Colombia Daclatasvir Sales and Growth Rate (2014-2019)
9 Middle East and Africa Daclatasvir by Countries
9.1 Middle East and Africa Daclatasvir Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Daclatasvir Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Daclatasvir Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Daclatasvir Sales and Growth Rate (2014-2019)
9.3 Turkey Daclatasvir Sales and Growth Rate (2014-2019)
9.4 Egypt Daclatasvir Sales and Growth Rate (2014-2019)
9.5 Nigeria Daclatasvir Sales and Growth Rate (2014-2019)
9.6 South Africa Daclatasvir Sales and Growth Rate (2014-2019)
10 Global Daclatasvir Market Segment by Type
10.1 Global Daclatasvir Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Daclatasvir Sales and Market Share by Type (2014-2019)
10.1.2 Global Daclatasvir Revenue and Market Share by Type (2014-2019)
10.2 30mg Tables Sales Growth and Price
10.2.1 Global 30mg Tables Sales Growth (2014-2019)
10.2.2 Global 30mg Tables Price (2014-2019)
10.3 60mg Tables Sales Growth and Price
10.3.1 Global 60mg Tables Sales Growth (2014-2019)
10.3.2 Global 60mg Tables Price (2014-2019)
11 Global Daclatasvir Market Segment by Application
11.1 Global Daclatasvir Sales Market Share by Application (2014-2019)
11.2 Hepatitis C Virus (HCV) Genotype 1 Sales Growth (2014-2019)
11.3 Hepatitis C Virus (HCV) Genotype 3 Sales Growth (2014-2019)
11.4 Hepatitis C Virus (HCV) Genotype 4 Sales Growth (2014-2019)
12 Daclatasvir Market Forecast (2019-2024)
12.1 Global Daclatasvir Sales, Revenue and Growth Rate (2019-2024)
12.2 Daclatasvir Market Forecast by Regions (2019-2024)
12.2.1 North America Daclatasvir Market Forecast (2019-2024)
12.2.2 Europe Daclatasvir Market Forecast (2019-2024)
12.2.3 Asia-Pacific Daclatasvir Market Forecast (2019-2024)
12.2.4 South America Daclatasvir Market Forecast (2019-2024)
12.2.5 Middle East and Africa Daclatasvir Market Forecast (2019-2024)
12.3 Daclatasvir Market Forecast by Type (2019-2024)
12.3.1 Global Daclatasvir Sales Forecast by Type (2019-2024)
12.3.2 Global Daclatasvir Market Share Forecast by Type (2019-2024)
12.4 Daclatasvir Market Forecast by Application (2019-2024)
12.4.1 Global Daclatasvir Sales Forecast by Application (2019-2024)
12.4.2 Global Daclatasvir Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Daclatasvir Picture
Table Product Specifications of Daclatasvir
Figure Global Sales Market Share of Daclatasvir by Types in 2018
Table Daclatasvir Types for Major Manufacturers
Figure 30mg Tables Picture
Figure 60mg Tables Picture
Figure Daclatasvir Sales Market Share by Applications in 2018
Figure Hepatitis C Virus (HCV) Genotype 1 Picture
Figure Hepatitis C Virus (HCV) Genotype 3 Picture
Figure Hepatitis C Virus (HCV) Genotype 4 Picture
Figure United States Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure France Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure UK Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure China Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure India Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Daclatasvir Revenue (Value) and Growth Rate (2014-2024)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Daclatasvir Type and Applications
Table Bristol-Myers Squibb Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Natco Pharma Basic Information, Manufacturing Base and Competitors
Table Natco Pharma Daclatasvir Type and Applications
Table Natco Pharma Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table Zydus Cadila Daclatasvir Type and Applications
Table Zydus Cadila Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs Daclatasvir Type and Applications
Table Hetero Drugs Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr Reddy's Laboratories Daclatasvir Type and Applications
Table Dr Reddy's Laboratories Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Daclatasvir Type and Applications
Table Cipla Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Daclatasvir Type and Applications
Table Mylan Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Daclatasvir Type and Applications
Table Abbott Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Emcure Pharmaceuticals Daclatasvir Type and Applications
Table Emcure Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Torrent Pharmaceuticals Daclatasvir Type and Applications
Table Torrent Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Daclatasvir Type and Applications
Table Biocon Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Daclatasvir Sales by Manufacturer (2017-2018)
Figure Global Daclatasvir Sales Market Share by Manufacturer in 2017
Figure Global Daclatasvir Sales Market Share by Manufacturer in 2018
Table Global Daclatasvir Revenue by Manufacturer (2017-2018)
Figure Global Daclatasvir Revenue Market Share by Manufacturer in 2017
Figure Global Daclatasvir Revenue Market Share by Manufacturer in 2018
Figure Top 3 Daclatasvir Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Daclatasvir Manufacturer (Revenue) Market Share in 2018
Figure Global Daclatasvir Sales and Growth Rate (2014-2019)
Figure Global Daclatasvir Revenue and Growth Rate (2014-2019)
Table Global Daclatasvir Sales by Regions (2014-2019)
Table Global Daclatasvir Sales Market Share by Regions (2014-2019)
Table Global Daclatasvir Revenue by Regions (2014-2019)
Figure Global Daclatasvir Revenue Market Share by Regions (2014-2019)
Figure Global Daclatasvir Revenue Market Share by Regions in 2018
Figure North America Daclatasvir Sales and Growth Rate (2014-2019)
Figure Europe Daclatasvir Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Daclatasvir Sales and Growth Rate (2014-2019)
Figure South America Daclatasvir Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Daclatasvir Sales and Growth Rate (2014-2019)
Figure North America Daclatasvir Revenue and Growth Rate (2014-2019)
Table North America Daclatasvir Sales by Countries (2014-2019)
Table North America Daclatasvir Sales Market Share by Countries (2014-2019)
Figure North America Daclatasvir Sales Market Share by Countries (2014-2019)
Figure North America Daclatasvir Sales Market Share by Countries in 2018
Table North America Daclatasvir Revenue by Countries (2014-2019)
Table North America Daclatasvir Revenue Market Share by Countries (2014-2019)
Figure North America Daclatasvir Revenue Market Share by Countries (2014-2019)
Figure North America Daclatasvir Revenue Market Share by Countries in 2018
Figure United States Daclatasvir Sales and Growth Rate (2014-2019)
Figure Canada Daclatasvir Sales and Growth Rate (2014-2019)
Figure Mexico Daclatasvir Sales and Growth Rate (2014-2019)
Figure Europe Daclatasvir Revenue and Growth Rate (2014-2019)
Table Europe Daclatasvir Sales by Countries (2014-2019)
Table Europe Daclatasvir Sales Market Share by Countries (2014-2019)
Table Europe Daclatasvir Revenue by Countries (2014-2019)
Figure Europe Daclatasvir Revenue Market Share by Countries (2014-2019)
Figure Europe Daclatasvir Revenue Market Share by Countries in 2018
Figure Germany Daclatasvir Sales and Growth Rate (2014-2019)
Figure UK Daclatasvir Sales and Growth Rate (2014-2019)
Figure France Daclatasvir Sales and Growth Rate (2014-2019)
Figure Russia Daclatasvir Sales and Growth Rate (2014-2019)
Figure Italy Daclatasvir Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Daclatasvir Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Daclatasvir Sales by Countries (2014-2019)
Table Asia-Pacific Daclatasvir Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Daclatasvir Sales Market Share by Countries 2018
Table Asia-Pacific Daclatasvir Revenue by Countries (2014-2019)
Figure Asia-Pacific Daclatasvir Revenue Market Share by Countries 2018
Figure China Daclatasvir Sales and Growth Rate (2014-2019)
Figure Japan Daclatasvir Sales and Growth Rate (2014-2019)
Figure Korea Daclatasvir Sales and Growth Rate (2014-2019)
Figure India Daclatasvir Sales and Growth Rate (2014-2019)
Figure Southeast Asia Daclatasvir Sales and Growth Rate (2014-2019)
Figure South America Daclatasvir Revenue and Growth Rate (2014-2019)
Table South America Daclatasvir Sales by Countries (2014-2019)
Table South America Daclatasvir Sales Market Share by Countries (2014-2019)
Figure South America Daclatasvir Sales Market Share by Countries in 2018
Table South America Daclatasvir Revenue by Countries (2014-2019)
Table South America Daclatasvir Revenue Market Share by Countries (2014-2019)
Figure South America Daclatasvir Revenue Market Share by Countries in 2018
Figure Brazil Daclatasvir Sales and Growth Rate (2014-2019)
Figure Argentina Daclatasvir Sales and Growth Rate (2014-2019)
Figure Colombia Daclatasvir Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Daclatasvir Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Daclatasvir Sales by Countries (2014-2019)
Table Middle East and Africa Daclatasvir Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Daclatasvir Sales Market Share by Countries in 2018
Table Middle East and Africa Daclatasvir Revenue by Countries (2014-2019)
Table Middle East and Africa Daclatasvir Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Daclatasvir Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Daclatasvir Revenue Market Share by Countries in 2018
Figure Saudi Arabia Daclatasvir Sales and Growth Rate (2014-2019)
Figure UAE Daclatasvir Sales and Growth Rate (2014-2019)
Figure Egypt Daclatasvir Sales and Growth Rate (2014-2019)
Figure Nigeria Daclatasvir Sales and Growth Rate (2014-2019)
Figure South Africa Daclatasvir Sales and Growth Rate (2014-2019)
Table Global Daclatasvir Sales by Type (2014-2019)
Table Global Daclatasvir Sales Share by Type (2014-2019)
Table Global Daclatasvir Revenue by Type (2014-2019)
Table Global Daclatasvir Revenue Share by Type (2014-2019)
Figure Global 30mg Tables Sales Growth (2014-2019)
Figure Global 30mg Tables Price (2014-2019)
Figure Global 60mg Tables Sales Growth (2014-2019)
Figure Global 60mg Tables Price (2014-2019)
Table Global Daclatasvir Sales by Application (2014-2019)
Table Global Daclatasvir Sales Share by Application (2014-2019)
Figure Global Hepatitis C Virus (HCV) Genotype 3 Sales Growth (2014-2019)
Figure Global Hepatitis C Virus (HCV) Genotype 4 Sales Growth (2014-2019)
Figure Global Daclatasvir Sales, Revenue and Growth Rate (2019-2024)
Table Global Daclatasvir Sales Forecast by Regions (2019-2024)
Table Global Daclatasvir Market Share Forecast by Regions (2019-2024)
Figure North America Sales Daclatasvir Market Forecast (2019-2024)
Figure Europe Sales Daclatasvir Market Forecast (2019-2024)
Figure Asia-Pacific Sales Daclatasvir Market Forecast (2019-2024)
Figure South America Sales Daclatasvir Market Forecast (2019-2024)
Figure Middle East and Africa Sales Daclatasvir Market Forecast (2019-2024)
Table Global Daclatasvir Sales Forecast by Type (2019-2024)
Table Global Daclatasvir Market Share Forecast by Type (2019-2024)
Table Global Daclatasvir Sales Forecast by Application (2019-2024)
Table Global Daclatasvir Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の予防的B型肝炎ウイルスワクチン市場：市場規模・現状・予測 The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer.The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth …- C型肝炎ウイルス抗ウイルス剤市場：世界及び中国市場分析・予測（～2024年） Hepatitis C Virus Hcv Antiviral Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Hepatitis C Virus Hcv Antiviral industry with a focus on the Chinese market. The report provides key statistics on the market status of the Hepati…
- ソホスブビル/レジパスビル合剤の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Sofosbuvir/Ledipasvir Compound Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the So…
- 世界のB型肝炎検査市場：市場規模・現状・予測 In 2018, the global Hepatitis B Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Hepatitis B Testing status, future forecast, growth opportunity, key market and key players. The study ob…
- 世界の肝炎検査診断市場：市場規模・現状・予測 Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…